Insider Trading March 30, 2026

Allient Vice President Sells $378,000 in Stock After Rally; Company Posts Strong Q4

Ashish Bendre disposes of 6,000 shares as Allient beats estimates and draws analyst price-target increases

By Ajmal Hussain ALNT
Allient Vice President Sells $378,000 in Stock After Rally; Company Posts Strong Q4
ALNT

Ashish Bendre, Allient INC's vice president and group president, sold 6,000 shares on March 27, 2026, for $63.00 per share, completing a $378,000 transaction. The sale comes after a 165% one-year jump in the stock that has since retreated to $59.52. Allient also reported a robust fourth quarter for 2025, with EPS and revenue topping forecasts and multiple analysts raising price targets.

Key Points

  • Ashish Bendre sold 6,000 Allient shares on March 27, 2026, at $63.00 per share for $378,000.
  • Following the sale, Bendre directly owns 20,197.975 shares and indirectly holds 1,155 shares through an ESOP Trust.
  • Allient’s Q4 2025 results beat expectations on EPS ($0.55 vs $0.45) and revenue ($143.4 million), prompting price-target increases from Roth/MKM and Craig-Hallum.

A senior executive at Allient INC executed a sizable stock sale late in March while the company reported a strong fourth-quarter performance for 2025.

On March 27, 2026, Ashish Bendre, who holds the titles of vice president and group president at Allient (NASDAQ:ALNT), sold 6,000 shares of the company's common stock at $63.00 per share. The transaction amounted to $378,000 in gross proceeds. After completing the sale, Bendre's direct ownership in Allient stands at 20,197.975 shares. Separately, he retains an indirect stake of 1,155 shares held through an ESOP Trust.

The insider sale occurred against the backdrop of notable share-price moves over the prior year. The stock had climbed 165% over the past 12 months before subsequently pulling back to trade at $59.52. The company’s recent quarterly results offer context for the market activity.

Allient reported fourth-quarter 2025 results that outperformed consensus estimates on both earnings and revenue. The company posted earnings per share of $0.55, which exceeded the consensus forecast of $0.45, a difference the company or analysts quantify as a 22.22% beat. Revenue for the quarter totaled $143.4 million, topping expectations by 7.93%.

Financial-market responses followed the quarterly release. Roth/MKM raised its price target on Allient to $69 from $56 and maintained a Buy rating, citing the strength of the quarter. Craig-Hallum also lifted its price target, moving it to $75 from $60, and characterized the quarter as one of the strongest in nearly a decade of the firm’s coverage.

Both the insider transaction and the company’s quarter are factual elements market participants can weigh when assessing Allient’s near-term profile. The company's reported results and the subsequent analyst target increases reflect positive analyst sentiment following the earnings release; the insider sale and the recent share-price pullback represent additional data points for investors to consider.


  • Transaction date and size: 6,000 shares sold on March 27, 2026, at $63.00, totaling $378,000.
  • Post-sale holdings: Direct ownership of 20,197.975 shares and indirect ownership of 1,155 shares via an ESOP Trust.
  • Quarterly results: Q4 2025 EPS of $0.55 versus $0.45 forecast (22.22% beat); revenue of $143.4 million, 7.93% above expectations.

Risks

  • Share-price volatility: the stock rose 165% over the past year but has pulled back to $59.52, indicating recent price movement that investors may find uncertain.
  • Insider disposition: the sale by a senior executive changes his direct ownership level and is a factor investors may consider when evaluating insider-driven signals.
  • Analyst expectations vs. execution: while analysts raised price targets after a strong quarter, future performance remains subject to company results and market reaction.

More from Insider Trading

Grocery Outlet Director Buys $882,500 in Stock as Shares Hover Near 52-Week Low Mar 30, 2026 Zevia CEO Sells 144,008 Shares to Cover RSU Taxes After Major Vesting Event Mar 30, 2026 Battalion Oil SVP Disposes of $28,662 in Shares as Company Navigates Asset Moves and Capacity Gains Mar 30, 2026 Castle Biosciences CEO Executes $106,598 Stock Sale as Company Posts Better-Than-Expected Q4 Results Mar 30, 2026 GitLab Director Disposes of $661,700 in Class A Shares Mar 30, 2026